{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:24Z","timestamp":1791214044306,"version":"4.1.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T00:00:00Z","timestamp":1370304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065362","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T21:57:27Z","timestamp":1370383047000},"page":"e65362","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Type 1 Interferons Inhibit Myotube Formation Independently of Upregulation of Interferon-Stimulated Gene 15"],"prefix":"10.1371","volume":"8","author":[{"given":"Sara","family":"Franzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Salajegheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remedios","family":"Nazareno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","article-title":"Molecular profiles of inflammatory myopathies","volume":"59","author":"SA Greenberg","year":"2002","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","article-title":"Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis","volume":"168","author":"Z Tezak","year":"2002","journal-title":"J Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"SA Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"RJ Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"M Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e31821f440a","article-title":"Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies","volume":"76","author":"C Cappelletti","year":"2011","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gene.2011.61","article-title":"Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis","volume":"13","author":"SA Greenberg","year":"2012","journal-title":"Genes Immun"},{"key":"ref8","first-page":"e21961","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases","volume":"7","author":"D Wong","year":"2011","journal-title":"PlosOne"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1600-0560.2009.01443.x","article-title":"The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis","volume":"37","author":"CM Magro","year":"2010","journal-title":"J Cutan Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.22558","article-title":"Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis","volume":"56","author":"CM Lopez de Padilla","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref11","first-page":"2813","article-title":"Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum","volume":"62","author":"S Shrestha","year":"2010"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon beta is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"AP Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(83)91771-3","article-title":"Immune interferon does not stimulate formation of alpha and beta interferon induced human lupus-type inclusions","volume":"1","author":"SA Rich","year":"1983","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/01913128609015565","article-title":"Formation of tubuloreticular inclusions in mitogen-stimulated human lymphocyte cultures by endogenous or exogenous alpha-interferon","volume":"10","author":"J Kuyama","year":"1986","journal-title":"Ultrastruct Pathol"},{"key":"ref15","first-page":"584","article-title":"Cultured human endothelial cells treated with recombinant leukocyte A interferon. Tubuloreticular inclusion formation, antiproliferative effect, and 2\u2032,5\u2032 oligoadenylate synthetase induction","volume":"58","author":"D Feldman","year":"1988","journal-title":"Lab Invest"},{"key":"ref16","first-page":"3480","article-title":"Formation of tubuloreticular inclusions in human lymphoma cells compared to the induction of 2\u2032-5\u2032-oligoadenylate synthetase by leucocyte interferon in dose-effect and kinetic studies","volume":"44","author":"PM Grimley","year":"1984","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"GR Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"J Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref19","first-page":"2726","article-title":"Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule","volume":"5","author":"JW Slaton","year":"1999","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Xiao HB, Zhou WY, Chen XF, Mei J, Lv ZW, <etal>et al<\/etal>.. (2011) Interferon-beta efficiently inhibited endothelial progenitor cell-induced tumor angiogenesis. Gene Ther.","DOI":"10.1038\/gt.2011.171"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"34677","DOI":"10.1074\/jbc.M110.164350","article-title":"Blocking interferon {beta} stimulates vascular smooth muscle cell proliferation and arteriogenesis","volume":"285","author":"SH Schirmer","year":"2010","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/emboj\/20.3.362","article-title":"Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein","volume":"20","author":"W Yuan","year":"2001","journal-title":"EMBO J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.0504754102","article-title":"Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways","volume":"102","author":"C Zhao","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1074\/jbc.M512830200","article-title":"Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells","volume":"281","author":"A Dastur","year":"2006","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1074\/jbc.M109078200","article-title":"UBP43 (USP18) specifically removes ISG15 from conjugated proteins","volume":"277","author":"MP Malakhov","year":"2002","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T18:15:46Z","timestamp":1563128146000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065362"}},"subtitle":[],"editor":[{"given":"Francisco Jos\u00e9","family":"Esteban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,4]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065362","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,4]]}}}